Search Login Register

asperlicin Summary

2 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: cholecystokinin antagonist; isolated from Aspergillus alliaceus; structure given in first source

Also Known As: (S-(2alpha,9beta,9(R*),9alpha,beta))-6,7-dihydro-7-((2,3,9,9a-tetrahydro-9-hydroxy-2-(2-methylpropyl)-3-oxo-1H-imidazo(1,2-a)indol-9-yl)methyl)quinazolino(3,2-a)(1,4)benzodiazepine-5,13-dione; Quinazolino(3,2-a)(1,4)benzodiazepine-5,13-dione, 6,7-dihydro-7-((2,3,9,9a-tetrahydro-9-hydroxy-2-(2-methylpropyl)-3-oxo-1H-imidazo(1,2-a)indol-9-yl)methyl)-, (2S-(2alpha,9beta,9(R*),9abeta))-

Key Diseases for which asperlicin is Relevant

  1. Pancreatitis : 1 result
  2. Pancreatic Neoplasms (Pancreatic Cancer) : 1 result

Drugs Related to asperlicin

  1. Cholecystokinin Receptors (Cholecystokinin Receptor)
  2. Devazepide
  3. Taurocholic Acid (Sodium Taurocholate)

Therapies Related to asperlicin


CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.